GET THE APP

Chemotherapy: Open Access

Chemotherapy: Open Access
Open Access

ISSN: 2167-7700

Chemotherapy: Open Access : Citations & Metrics Report

Articles published in Chemotherapy: Open Access have been cited by esteemed scholars and scientists all around the world. Chemotherapy: Open Access has got h-index 12, which means every article in Chemotherapy: Open Access has got 12 average citations.

Following are the list of articles that have cited the articles published in Chemotherapy: Open Access.

  2021 2020 2019 2018 2017 2016

Year wise published articles

30 8 0 17 24 52

Year wise citations received

61 68 83 58 143 116
Journal total citations count 709
Journal impact factor 1.81
Journal 5 years impact factor 3.80
Journal cite score 4.89
Journal h-index 12
Journal h-index since 2018 9
Important citations (402)

mohamed rh, abu-shahba n, mahmoud m, abdelfattah am, zakaria w, et al. co-regulatory network of oncosuppressor mirnas and transcription factors for pathology of human hepatic cancer stem cells (hcsc). scientific reports. 2019;9(1):5564.

АМЕТОВ АС, ГУСЕНБЕКОВА ДГ. treatment of type 2 diabetes using the fixed combination of metformin and glibenclamide. therapy. 2017; 4: 119-123.

kato j, shirakami y, shimizu m. diabetes mellitus and colon carcinogenesis: expectation for inhibition of colon carcinogenesis by oral hypoglycemic drugs. gastrointestinal disorders. 2019;1(2):273-289.

aljofan m, riethmacher d. anticancer activity of metformin: a systematic review of the literature. future science oa. 2019;5(8):fso410.

lu cc, chiang jh, tsai fj, hsu ym, juan yn, et al. metformin triggers the intrinsic apoptotic response in human ags gastric adenocarcinoma cells by activating ampk and suppressing mtor/akt signaling. international journal of oncology. 2019;54(4):1271-1281.

mallik r, chowdhury ta. metformin in cancer. diabetes research and clinical practice. 2018;143:409-419.

crawford a, haber l, kelly mp, vazzana k, canova l, et al. a mucin 16 bispecific t cell–engaging antibody for the treatment of ovarian cancer. science translational medicine. 2019;11(497):eaau7534.

li x, pasche b, zhang w, chen k. association of muc16 mutation with tumor mutation load and outcomes in patients with gastric cancer. jama oncology. 2018;4(12):1691-1698.

dattaprasad d, thirumalarao kr. effect of diallyl disulfide on liver lipid alterations in experimentally induced hepatoma in mice. 2019;98087.

dattaprasad d, vickram kr. effect of diallyl disulfide on liver lipid alterations in experimentally induced hepatoma in mice.

lee ec, elhassan sa, lim gp, kok wh, tan sw, et al. the roles of circular rnas in human development and diseases. biomedicine & pharmacotherapy. 2019;111:198-208.

sakuma k, hanyu s, takahashi h, tanaka a. identification of the optimal cetuximab concentration that is effective against oral squamous cell carcinoma in collagen gel droplet embedded culture drug sensitivity testing. molecular and clinical oncology.

hanafy as. efficacy of low dose capecitabine and sorafenib in patients with advanced alfa-fetoprotein secreting hepatocellular carcinoma: a 1 year experience.springerplus.2016;5(1):1675.

sousa jl (2014) toxicity of the antitumor drug mitoxantrone in pediatric and adult mice.

renner p, horneber m (2015) cam-cancer consortium. l-carnitine.

aysan e, bayrak of, aydemir e, telci d, sahin f, et al. (2013) cancer preventive effects of whole cell type immunization against mice ehrlich tumors. asian pacific journal of cancer prevention 14: 3515-3519.

roesmann a, afify m, panse j, eisert a, steitz j, et al. (2013) l-carnitine ameliorates l-asparaginase-induced acute liver toxicity in steatotic rat livers. chemotherapy 59: 167-75.

dores-sousa jl, duarte ja, seabra v, de lourdes bastos m, carvalho f, et al. (2015) the age factor for mitoxantrone’s cardiotoxicity: multiple doses render the adult mouse heart more susceptible to injury. toxicology 329: 106-19.

prasanthi d (2016) anticancer drugs used in treatment of curing cancer. research & reviews: journal of pharmacology and toxicological studies 4: 1-7

durosinmi ma (2016) burkitt lymphoma: a potentially curable childhood tumour: experience in ile-ife, nigeria (1986-2014). annals of health research 2: 1-9.

Top